论文部分内容阅读
利用抗IL—6、IL—6R抗体，使用免疫组化的方法。直接标记肺癌组织标本，探讨IL—6、IL—6R与肺癌的发生、发展及预后的关系。
Using anti-IL-6, IL-6R antibodies, immunohistochemistry was used. Directly labeling lung cancer tissue samples to explore the relationship between IL-6, IL-6R and the occurrence, development and prognosis of lung cancer.